⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 2, 2025Open Access

Figure S5 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications

Sreekumar Balan Liam O’Brien Ante Peros Xuedi Wang Ingrid Leal Rojas Christopher B. McClain Kristen J. Radford Nina Bhardwaj

View Full Paper

Ask AI

Bookmark

Share

Key Points

Enhanced cytokine production in dendritic cells indicates improved immune response against cancer, which may lead to better patient outcomes.
Dendritic cells generated via optimized culture methods displayed significantly increased cross presentation abilities, enhancing their effectiveness.
Investigating different culture methods reveals critical insights for optimizing dendritic cell functionality in cancer immunotherapy applications.
Findings support the potential of manipulating notch signaling pathways in developing effective cancer immunotherapy strategies.

Implication

Analysis of cytokine production and cross presentation in dendritic cells, suggesting methods to improve cancer therapies.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Balan et al. (2025) studied this question.

synapsesocial.com/papers/68bb4e016d6d5674bcd02929 https://doi.org/10.1158/2326-6066.30028876

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S4 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications2025
2Figure S2 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications2025
3Figure S3 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications2025
4Figure S1 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications2025
5Figure S6 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications2025

Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells2018
Figure S2 from High Levels of Endogenous Omega-3 Fatty Acids Promote Dendritic Cell Antigen Presentation and Improve Dendritic Cell–Based Cancer Vaccine Efficacy in Mice2025
Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4+ T cell help2026